Bank of New York Mellon’s Jade Biosciences, Inc. Common Stock JBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $783K | Buy |
78,393
+77,349
| +7,409% | +$773K | ﹤0.01% | 3239 |
|
|
2025
Q1 | $91.7K | Sell |
1,044
-32
| -3% | -$2.81K | ﹤0.01% | 3990 |
|
|
2024
Q4 | $99.8K | Sell |
1,076
-109
| -9% | -$10.1K | ﹤0.01% | 4011 |
|
|
2024
Q3 | $86.7K | Sell |
1,185
-158
| -12% | -$11.6K | ﹤0.01% | 4010 |
|
|
2024
Q2 | $78K | Buy |
1,343
+553
| +70% | +$32.1K | ﹤0.01% | 4036 |
|
|
2024
Q1 | $818K | Sell |
790
-255
| -24% | -$264K | ﹤0.01% | 3251 |
|
|
2023
Q4 | $827K | Buy |
1,045
+262
| +33% | +$207K | ﹤0.01% | 3284 |
|
|
2023
Q3 | $372K | Buy |
783
+5
| +0.6% | +$2.38K | ﹤0.01% | 3700 |
|
|
2023
Q2 | $467K | Sell |
778
-16
| -2% | -$9.61K | ﹤0.01% | 3631 |
|
|
2023
Q1 | $561K | Sell |
794
-9
| -1% | -$6.36K | ﹤0.01% | 3434 |
|
|
2022
Q4 | $823K | Buy |
803
+16
| +2% | +$16.4K | ﹤0.01% | 3292 |
|
|
2022
Q3 | $457K | Buy |
787
+71
| +10% | +$41.2K | ﹤0.01% | 3609 |
|
|
2022
Q2 | $392K | Sell |
716
-155
| -18% | -$84.9K | ﹤0.01% | 3734 |
|
|
2022
Q1 | $559K | Buy |
871
+191
| +28% | +$123K | ﹤0.01% | 3641 |
|
|
2021
Q4 | $281K | Buy |
680
+57
| +9% | +$23.6K | ﹤0.01% | 4124 |
|
|
2021
Q3 | $457K | Buy |
+623
| New | +$457K | ﹤0.01% | 3859 |
|